West S A, Sax K W, Stanton S P, Keck P E, McElroy S L, Strakowski S M
Biological Psychiatry Program, University of Gincinati College of Medicine, OH, USA.
Psychopharmacol Bull. 1996;32(1):63-6.
The purpose of this study was to compare basal thyroid indices in adolescent (ages 12 to 18) bipolar patients with and without attention deficit hyperactivity disorder (ADHD). On the basis of earlier studies, the authors hypothesized that bipolar patients with comorbid ADHD would have lower serum triiodothyronine (T3) and thyroxine (T4) concentrations and higher serum thyroid stimulating hormone (TSH) concentrations compared with patients with bipolar disorder alone. Thirty adolescents who met DSM-III-R criteria for bipolar disorder and were hospitalized for the treatment of acute mania were assessed. Twenty patients (66%) had comorbid ADHD. The mean serum T4 concentration in this group was significantly lower than it was for patients with bipolar disorder alone. There were no significant differences between groups in serum T3 or TSH concentrations. Although, these data are preliminary and require further investigation, this may have important implications regarding the potential benefits of thyroid supplementation in adolescents with bipolar disorder and comorbid ADHD who do not respond to mood stabilizers alone.
本研究的目的是比较患有和未患有注意力缺陷多动障碍(ADHD)的青少年(12至18岁)双相情感障碍患者的基础甲状腺指标。基于早期研究,作者推测,与仅患有双相情感障碍的患者相比,合并ADHD的双相情感障碍患者血清三碘甲状腺原氨酸(T3)和甲状腺素(T4)浓度会更低,而血清促甲状腺激素(TSH)浓度会更高。对30名符合DSM-III-R双相情感障碍标准且因急性躁狂发作住院治疗的青少年进行了评估。20名患者(66%)合并ADHD。该组患者的平均血清T4浓度显著低于仅患有双相情感障碍的患者。两组之间的血清T3或TSH浓度无显著差异。尽管这些数据是初步的,需要进一步研究,但这可能对单独使用心境稳定剂无反应的合并ADHD的双相情感障碍青少年补充甲状腺素的潜在益处具有重要意义。